High-resolution aberrometry

Article

Even without refned nomograms, new-generation aberrometry is contributing to better results

We have consistently found that uncorrected distance vision is the best predictor of patient satisfaction after laser vision correction. Moreover, every line of visual acuity, even beyond the 'ideal' of 20/20, results in greater patient satisfaction with the procedure and a greater likelihood of positive referrals.

Optical Express centres in the UK have been evaluating the efficacy of a new high-resolution aberrometer (iDesign, Abbott Medical Optics, Santa Ana, California, USA) for wavefront-guided laser vision correction.

Study design and results

The performance of the new aberrometer was evaluated in 675 eyes of 348 patients undergoing refractive surgery between May and October 2012. These patients presented with a wide range of preoperative refractive error. Preoperative sphere ranged from –9.50 D to +4.25 D (mean: –1.86 ± 2.42 D) and preoperative cylinder was as much as 5.50 D in some eyes (mean: –0.76 ± 0.83 D).

At one month, 90% of all eyes had a manifest spherical equivalent (MSE) within 0.50 D of intended correction and 97% were within 1.00 D. The linear regression for attempted versus achieved MSE was 1.01, with a very strong correlation coefficient (0.97). Monocular uncorrected visual acuity (UCVA) was 20/25 or better in 93% of eyes and 20/16 or better in more than 70% of eyes.

Most impressive were the astigmatism correction results. One month postoperatively, the mean cylinder had been reduced to –0.18 ± 0.25 D, and 95% of the eyes had visually insignificant (less than 0.5 D) of cylinder. This is the best cylinder correction I have ever seen following an excimer laser procedure.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
© 2025 MJH Life Sciences

All rights reserved.